Skip to main content

Table 3 Subgroup analysis of neoadjuvant chemoradiotherapy (NACRT) and upfront surgery patients

From: A lower cut-off for lymph node harvest predicts for poorer overall survival after rectal surgery post neoadjuvant chemoradiotherapy

VariablesCategoryNDisease-free survivalOverall survival
Median ± SD (months)P valueMedian ± SD (months)P value
NACRT group (N= 94)
 Tumour stagingStage 11888 ± 390.02688 ± 390.051
Stage 23273 ± 4076 ± 39
Stage 34467 ± 3774 ± 36
 Lymph node harvest< 123661 ± 380.80163 ± 410.436
≥ 125880 ± 4086 ± 39
Upfront surgery group (N= 163)
 Tumour stagingStage 14382 ± 380.00184 ± 410.003
Stage 22961 ± 3768 ± 40
Stage 39154 ± 3560 ± 37
 Lymph node harvest< 121761 ± 380.04061 ± 390.013
≥ 1214663 ± 4168 ± 38